Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 41789 [2012-17313]
Download as PDF
Federal Register / Vol. 77, No. 136 / Monday, July 16, 2012 / Notices
background material on its Web site
prior to the meeting, it will be made
publicly available at the location of the
advisory committee meeting, and the
background material will be posted on
ONC’s Web site after the meeting, at
https://healthit.hhs.gov.
Procedure: ONC is committed to the
orderly conduct of its advisory
committee meetings. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the Committee. Written
submissions may be made to the contact
person on or before two days prior to
the Committee’s meeting date. Oral
comments from the public will be
scheduled in the agenda. Time allotted
for each presentation will be limited to
three minutes. If the number of speakers
requesting to comment is greater than
can be reasonably accommodated
during the scheduled public comment
period, ONC will take written comments
after the meeting until close of business
on that day.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee
meetings. Seating is limited at the
location, and ONC will make every
effort to accommodate persons with
physical disabilities or special needs. If
you require special accommodations
due to a disability, please contact
MacKenzie Robertson at least seven (7)
days in advance of the meeting.
Notice of this meeting is given under
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: July 5, 2012.
MacKenzie Robertson,
FACA Program Lead, Office of Policy and
Planning, Office of the National Coordinator
for Health Information Technology.
[FR Doc. 2012–17288 Filed 7–13–12; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Department of Health and
Human Services, Office of the Assistant
Secretary for Health, Presidential
Commission for the Study of Bioethical
Issues.
ACTION: Notice of meeting.
srobinson on DSK4SPTVN1PROD with NOTICES
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues will
conduct its tenth meeting in August. At
SUMMARY:
VerDate Mar<15>2010
16:32 Jul 13, 2012
Jkt 226001
this meeting, the Commission will
continue discussing topics related to the
ethical issues associated with the
development of medical
countermeasures for children. The
Commission will also develop and
finalize recommendations regarding
access to, and privacy of human genome
sequence data.
DATES: The meeting will take place
Wednesday and Thursday, August 1–2,
2012.
ADDRESSES: Renaissance Washington,
DC Downtown Hotel, 999 9th Street
NW., Washington, DC 20001. Telephone
(202) 898–9000.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues, 1425
New York Avenue NW., Suite C–100,
Washington, DC 20005. Telephone:
202–233–3960. Email:
Hillary.Viers@bioethics.gov. Additional
information may be obtained at
www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
tenth meeting of the Presidential
Commission for the Study of Bioethical
Issues (the Commission). The meeting
will be held from 9 a.m. to
approximately 5:30 p.m. on Wednesday,
August 1, 2012, and from 9 a.m. to
approximately 4 p.m. on Thursday,
August 2, 2012, in Washington, DC. The
meeting will be open to the public with
attendance limited to space available.
The meeting will also be webcast at
www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an advisory panel of
the nation’s leaders in medicine,
science, ethics, religion, law, and
engineering. The Commission advises
the President on bioethical issues
arising from advances in biomedicine
and related areas of science and
technology. The Commission seeks to
identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda item for the
Commission’s tenth meeting is to
continue discussing topics related to the
ethical issues associated with the
development of medical
countermeasures for children. The
Commission will also develop and
finalize recommendations regarding
access to, and privacy of human genome
sequence data.
PO 00000
Frm 00049
Fmt 4703
Sfmt 9990
41789
The draft meeting agenda and other
information about PCSBI, including
information about access to the webcast,
will be available at www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful debate of opposing views
and active participation by citizens in
public exchange of ideas enhances
overall public understanding of the
issues at hand and conclusions reached
by the Commission. The Commission is
particularly interested in receiving
comments and questions during the
meeting that are responsive to specific
sessions. Written comments will be
accepted at the registration desk and
comment forms will be provided to
members of the public in order to write
down questions and comments for the
Commission as they arise. To
accommodate as many individuals as
possible, the time for each question or
comment may be limited. If the number
of individuals wishing to pose a
question or make a comment is greater
than can reasonably be accommodated
during the scheduled meeting, the
Commission may make a random
selection.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 233–3960, or email at
Esther.Yoo@bioethics.gov in advance of
the meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Written comments will also be
accepted in advance of the meeting and
are especially welcome. Please address
written comments by email to
info@bioethics.gov, or by mail to the
following address: Public Commentary,
Presidential Commission for the Study
of Bioethical Issues, 1425 New York
Ave. NW., Suite C–100, Washington, DC
20005. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Dated: July 9, 2012.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2012–17313 Filed 7–13–12; 8:45 am]
BILLING CODE 4154–06–P
E:\FR\FM\16JYN1.SGM
16JYN1
Agencies
[Federal Register Volume 77, Number 136 (Monday, July 16, 2012)]
[Notices]
[Page 41789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17313]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Department of Health and Human Services, Office of the
Assistant Secretary for Health, Presidential Commission for the Study
of Bioethical Issues.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
will conduct its tenth meeting in August. At this meeting, the
Commission will continue discussing topics related to the ethical
issues associated with the development of medical countermeasures for
children. The Commission will also develop and finalize recommendations
regarding access to, and privacy of human genome sequence data.
DATES: The meeting will take place Wednesday and Thursday, August 1-2,
2012.
ADDRESSES: Renaissance Washington, DC Downtown Hotel, 999 9th Street
NW., Washington, DC 20001. Telephone (202) 898-9000.
FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications
Director, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone:
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional
information may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the tenth meeting of the Presidential Commission for the Study of
Bioethical Issues (the Commission). The meeting will be held from 9
a.m. to approximately 5:30 p.m. on Wednesday, August 1, 2012, and from
9 a.m. to approximately 4 p.m. on Thursday, August 2, 2012, in
Washington, DC. The meeting will be open to the public with attendance
limited to space available. The meeting will also be webcast at
www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Commission. The Commission is an advisory
panel of the nation's leaders in medicine, science, ethics, religion,
law, and engineering. The Commission advises the President on
bioethical issues arising from advances in biomedicine and related
areas of science and technology. The Commission seeks to identify and
promote policies and practices that ensure scientific research, health
care delivery, and technological innovation are conducted in a socially
and ethically responsible manner.
The main agenda item for the Commission's tenth meeting is to
continue discussing topics related to the ethical issues associated
with the development of medical countermeasures for children. The
Commission will also develop and finalize recommendations regarding
access to, and privacy of human genome sequence data.
The draft meeting agenda and other information about PCSBI,
including information about access to the webcast, will be available at
www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Respectful debate of opposing views and
active participation by citizens in public exchange of ideas enhances
overall public understanding of the issues at hand and conclusions
reached by the Commission. The Commission is particularly interested in
receiving comments and questions during the meeting that are responsive
to specific sessions. Written comments will be accepted at the
registration desk and comment forms will be provided to members of the
public in order to write down questions and comments for the Commission
as they arise. To accommodate as many individuals as possible, the time
for each question or comment may be limited. If the number of
individuals wishing to pose a question or make a comment is greater
than can reasonably be accommodated during the scheduled meeting, the
Commission may make a random selection.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting.
The Commission will make every effort to accommodate persons who need
special assistance.
Written comments will also be accepted in advance of the meeting
and are especially welcome. Please address written comments by email to
info@bioethics.gov, or by mail to the following address: Public
Commentary, Presidential Commission for the Study of Bioethical Issues,
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Comments
will be publicly available, including any personally identifiable or
confidential business information that they contain. Trade secrets
should not be submitted.
Dated: July 9, 2012.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2012-17313 Filed 7-13-12; 8:45 am]
BILLING CODE 4154-06-P